| Organ system | Toxicity levels reported | Reported effects |
| Pulmonary | 0.015–0.13 mg Co/m3 | Pulmonary compromise, pulmonary inflammation, granulomatous lung disease, restrictive lung disease, pulmonary fibrosis, fibrosing alveolitis, asthma-like syndrome |
| Hematological | ∼1 mg Co/kg/day | Increased levels of erythrocytes and hemoglobin, i.e., polycythemia (levels normalize 9–15 days after cessation) |
| Cardiovascular | 0.04 mg Co/kg/day to 0.14 mg Co/kg/day | Beer-drinkers’ cardiomyopathy, sinus tachycardia, left ventricular failure, cardiogenic shock, diminished myocardial compliance, absence of myocardial response to exercise or catecholamine, enlarged heart, pericardial effusion, extensive intracellular changes (changes in the myofibers, mitochondria, glycogen, and lipids), pathological changes in myocardiaum including proliferative interstitial tissue, swollen muscle fibers, and focal degeneration. |
| Gastrointestinal | 0.04 mg Co/kg/day | Nausea, vomiting, diarrhea, |
| Hepatic effects | 0.04 mg Co/kg/day | Central hepatic necrosis, increased serum bilirubin, increase aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactic acid dehydrogenase (LDH), increase creatine phosphokinase, increase ornithine carbamyl transferase, isocitric dehydrogenase, and aldolase |
| Endocrine | 0.066 mg Co/kg/day | Histological morphology: irregular follicles, decreased follicular size, goiter, hypothyroidism, thyroid hypoplasia, thyroid hypertrophy, thyroid hyperplasia, thyroid firmness |
| Dermatological | 0.014 mg/kg/day | Allergic dermatitis, eczema flares, |
| Ophthalmological | 1.3 mg Co/kg/day | Severe visual disturbance (optic atrophy, impaired choroidal perfusion), implant-related chorio-retinal cobalt toxicity, patchy degeneration of the photoreceptor-retinal pigment epithelium (RPE) complex, toxic retinopathy |
| Neurological | Serum levels > 0.01 mg | Memory impairment, altered mental status, deafness, vertigo, seizures, tremors |
| Psychiatric | Serum levels > 0.01 mg | Depression |
|
|